Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis
Idiopathic Scoliosis, Post-operative Pain
About this trial
This is an interventional treatment trial for Idiopathic Scoliosis
Eligibility Criteria
Inclusion Criteria:
- ASA I, II, III
- Presenting for spinal fusion for idiopathic scoliosis
- English-speaking and able to give assent
Exclusion Criteria:
- Any contraindication to ketamine
- Previous spinal surgery
- Opioid dependence
- Chronic pain condition
- Significant developmental delay
- Pregnancy
Sites / Locations
- Albany Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Treatment Group
Placebo
A ketamine bolus of 0.5mg/kg will be given and then the ketamine infusion of 0.2 mg/kg/hr will be initiated prior to incision. Intra-operative opioids will be at the discretion of the attending anesthesiologist. Postoperative management will include continuation of the study drug as well as a standardized morphine patient-controlled analgesia (PCA) and acetaminophen 15 mg/kg IV every 6 hours. On postoperative day 1, patients are started on ketorolac 0.5 mg/kg up to 15 mg IV q8h. On postoperative day 2 they are transitioned to ibuprofen 10 mg/kg up to 600 mg. The ketamine infusion will continue for 48 hours post operatively at which point the PCA is discontinued and patients are transitioned to oral pain medications (Roxicet or Lortab and Flexeril) as per the current protocol.
A placebo (saline) will be given in place of ketamine